MiniMed Board of Directors

Board Chair & Indepdent Director

Retired Chief Executive Officer, CommonSpirit Health

• Kevin served as Chief Executive Officer Emeritus of CommonSpirit Health, prior to retiring in 2020 after overseeing the 2019 merger between Catholic Health Initiatives (CHI) and Dignity Health that formed one of the largest nonprofit health systems in the U.S.
• Previously served for nearly two decades as Chief Executive Officer of Catholic Health Initiatives (CHI), leading its significant growth and transformation.
• Held earlier leadership roles as Executive Director and Chief Executive Officer of Howard University Hospital and UAB Hospital in Birmingham.
• Kevin is a Life Fellow of the American College of Healthcare Executives, a Board member of Howard University, and Chair of the Board of the Georgia State University Foundation. Kevin currently serves on the Board of Directors of Medtronic plc. He previously served on the boards of Gilead Sciences, Inc., Rite Aid Corporation and Morehouse School of Medicine.
• Kevin earned a Bachelor of Science (B.S.) from Boston University Questrom School of Business and a Master of Healthcare Administration (M.H.A.) from Georgia State University.

Chief Executive Officer, MiniMed
 

• Que Dallara is Chief Executive Officer and a member of the Board of Directors of MiniMed. She joined the company in 2022 and has led the business through its separation from Medtronic and its Nasdaq listing in March 2026. 
• She brings more than two decades of global leadership experience across healthcare, software, industrial, and manufacturing sectors, with a strong track record of driving growth and building high-performance teams.
• Prior to MiniMed, she served as President and CEO of Honeywell Connected Enterprise and as Senior Vice President and Chief Commercial Officer at Honeywell, where she led the company’s efforts in strategy, marketing, sales excellence, pricing, product innovation, enterprise software, data analytics, and IoT solutions. 
• Earlier in her career, she held leadership roles at TE Connectivity, Microsoft, Telstra, and McKinsey & Company.
• Since November 2023, Que has served as an independent director of Lattice Unclear where Semiconductor (NASDAQ: LSCC).
• She holds a Bachelor of Science in Applied Mathematics with First Class Honours and a Bachelor of Commerce in Finance, both from the University of New South Wales, Sydney, Australia; and an MBA from INSEAD in Fontainebleau, France.

Independent Director
 

Executive Vice President, Enterprise Pharmacy, Walgreens
 

• Amy serves as Executive Vice President, Enterprise Pharmacy at Walgreens, where she leads the company's community and specialty pharmacy strategy and operations.
• A pharmacist by training, Amy brings more than 25 years of experience across pharmacy benefit management, consumer healthcare, retail pharmacy and government healthcare programs.
• Prior to Walgreens, Amy served as President of Express Scripts, the nation's largest pharmacy benefit manager, where she oversaw a business with more than $100 billion in annual revenue serving more than 100 million covered lives. During her tenure, she drove growth and innovation with a focus on improving affordability and access to pharmaceuticals.
• Amy previously served as a Commissioner on the Medicare Payment Advisory Commission (MedPAC), advising policymakers on healthcare reimbursement and pharmacy-related issues.
• Amy earned a Bachelor of Science (B.S.) in Pharmacy from the University of Health Sciences and Pharmacy in St. Louis.

Independent Director
 

Former Executive Vice President and Chief Financial Officer, Labcorp Holdings Inc.

• Glenn served as Executive Vice President and Chief Financial Officer of Labcorp from mid-2014 until December 2024 and continued as Special Advisor to the CEO through April 2025 to ensure a smooth transition.
• Over the course of his tenure, Glenn helped steer Labcorp through approximately 100 acquisitions, deploying about $11 billion into growth and delivering strong shareholder returns.
• Prior to joining Labcorp, Glenn served as Executive Vice President of Finance and Administration and Chief Financial Officer at The Timken Company, a leading global manufacturer of engineered bearings and power transmission products. Earlier in his career, he was President and Chief Operating Officer of United Dominion Industries, a global diversified industrial company, after holding several executive positions there, including Chief Financial Officer and President of its Test Instrumentation segment.
• Glenn currently serves on the Boards of Directors of Solventum (NYSE: SOLV), Lumexa Imaging (Nasdaq: LMRI) and Middleby (Nasdaq: MIDD). He previously served on the public boards of Family Dollar Stores, Inc., Perspecta Inc., US Ecology, Inc., and Alpha Natural Resources, Inc.
• Glenn earned a Bachelor of Arts (B.A.) from Tulane University and a Master of Business Administration (M.B.A.) from Georgia State University.

Independent Director

Chief Executive Officer, Alcon

• David has served as Chief Executive Officer of Alcon since July 2018 and has been a member of the company's Board of Directors since 2019. He joined Alcon in 2016 as Chief Operating Officer. During his tenure he led the company's spin out and return to the public markets.
• Prior to joining Alcon, David served as President of Hospira Infusion Systems, a Pfizer company. Earlier in his career, he spent more than 25 years at Allergan, where he held leadership roles across the United States, Europe, Asia, and Latin America and served as an officer and member of the company's Executive Committee.
• David currently serves on the Board of Directors of AdvaMed. He previously served on the Boards of Directors of Zeltiq, Inc. and Orexigen Therapeutics, Inc.
• David earned a Bachelor of Arts (B.A.) in Chemistry from Whitman College and a Master of Business Administration (M.B.A.) from the University of Southern California.

Independent Director

Former President and Chief Executive Officer, Nevro Corp

• Keith served as President and Chief Executive Officer of Nevro from March 2019 to April 2023, then transitioned to Executive Chairman and later to Non-Executive Chairman of the Board.
• Keith is a four-time public company CEO and has served as a board member of nine public and eight private companies. As CEO or Director, he has led or participated in billions of dollars of shareholder value creation driven by organic enterprise growth.
• Keith brings more than 35 years of leadership in medical devices, with notable tenures at Thoratec Corporation (leading growth culminating in a $3.4B sale to St. Jude), Conceptus, Inc. (guided to eventual sale to Bayer), and as Managing Director at Texas Pacific Group.
• Keith currently serves as Vice Chairman of Alcon, Inc., Chairman of Outset Medical, Inc. and has held board roles at  Intuitive Surgical, Inc., Kyphon, Inc., Zeltiq, Inc., and several privately held medical device companies.
• Keith earned a Bachelor of Science in Life Sciences (B.S.) from The Ohio State University and a Master of Business Administration (M.B.A.) from Pepperdine University.

Director

Senior Vice President, Head of Global Strategy, Medtronic

• Bob serves as the Senior Vice President and Head of Global Strategy at Medtronic, where he steers the company’s strategic direction with an emphasis on capital allocation and portfolio oversight.
• Bob joined Medtronic in November 2021 from Bank of America Merrill Lynch, where he was a Managing Director and Senior Equity Research Analyst covering the medical technology industry, including Medtronic.
• Bob holds more than 25 years of extensive MedTech experience and has been consistently recognized as a leading industry analyst.
• Bob previously served as a Managing Director at Lehman Brothers Holdings Inc., as well as a Vice President at Donaldson, Lufkin & Jenrette.
• Bob earned a Bachelor of Arts (B.A.) in Political Science from Trinity College (Hartford) and a Master of Business Administration (M.B.A.) from Columbia Business School. 

Independent Director

Former Executive Vice President and Chief Financial Officer, Optum

• Tim is the retired Executive Vice President & Chief Financial Officer of Optum, where he steered major divisions including Optum Financial, Supply Chain, and OptumRx after nearly 20 years with UnitedHealth Group.
• Tim held leadership roles across Optum’s spectrum of operations, product, business development, and strategic relationships, and he also served on the board of Optum360.
• After leaving Optum, Tim was tapped as advisory board chair at MOBE and joined BrightSpring’s Board of Directors in April 2024.
• Tim has served on the boards of two public companies: Precision Castparts Corp. (sold to Berkshire Hathaway for $37B) and Aerojet Rocketdyne. He served on both companies' Finance and Audit Committees and is recognized as an SEC financial expert. He is also actively engaged in supporting the growth of several private companies.
• Tim earned a Bachelor of Arts (B.A.) in Economics from the University of Chicago and a Master of Business Administration (M.B.A.) from Harvard University Graduate School of Business.